Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 12-2011 | |
| Sales | 290 | 472 | 0 | 528 | 0 |
| Gross Profit | 290 | 472 | N/A | 528 | N/A |
| Operating Expenses | 4,559 | 3,828 | 0 | 4,178 | 0 |
| Operating Income | -4,269 | -3,356 | N/A | -3,650 | N/A |
| Interest Expense | 88 | 100 | 0 | 0 | 0 |
| Other Income | -1,177 | -92 | 0 | -463 | 0 |
| Pre-tax Income | -5,534 | -3,548 | 0 | -4,113 | 0 |
| Net Income Continuous | -5,534 | -3,548 | N/A | -4,113 | N/A |
| Net Income | $-5,534 | $-3,548 | $N/A | $-4,113 | $N/A |
| EPS Basic Total Ops | -4.46 | -2.92 | N/A | -3.51 | N/A |
| EPS Basic Continuous Ops | -4.46 | -2.93 | N/A | -3.51 | N/A |
| EPS Diluted Total Ops | -4.46 | -2.92 | N/A | -3.51 | N/A |
| EPS Diluted Continuous Ops | -4.46 | -2.93 | N/A | -3.51 | N/A |
| EBITDA(a) | $-4,107 | $-3,181 | $N/A | $-3,650 | $N/A |